Title
|
|
|
|
Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon
| |
Author
|
|
|
|
| |
Abstract
|
|
|
|
BackgroundSurveys conducted in 1991-1992 in the Mbam Valley (Cameroon) revealed that onchocerciasis was highly endemic, with community microfilarial loads (CMFL)>100 microfilariae/snip in some villages. Also in 1991-1992, a survey of suspected cases of epilepsy (SCE) found 746 SCE using a questionnaire administered to individuals identified by key informants, with prevalences reaching 13.6% in some communities. From 1998, annual community-directed treatment with ivermectin (CDTI) was implemented to control onchocerciasis. In 2017, a door-to-door household survey was conducted in three of the villages visited in 1991-1992, using a standardized 5-item epilepsy screening questionnaire.ResultsIn 2017, a total of 2286 individuals living in 324 households were screened (582 in Bayomen, 553 in Ngongol and 1151 in Nyamongo) and 112 SCE were identified (4.9%). Neurologists examined 92 of these SCE and confirmed the diagnosis of epilepsy for 81 of them (3.5%). Between the surveys in 1991-1992 and 2017, the prevalence of SCE decreased from 13.6% to 2.5% in Bayomen (P=0.001), from 8.7% to 6.6% in Ngongol (P=0.205) and from 6.4% to 5.4% in Nyamongo (P=0.282). The median age of SCE shifted from 20 (IQR: 12-23) to 29years (IQR: 18-33; P=0.018) in Bayomen, from 16 (IQR: 12-21) to 26years (IQR: 21-39; P<0.001) in Ngongol and from 16 (IQR: 13-19) to 24years (IQR: 19-32; P<0.001) in Nyamongo. The proportions of SCE aged <10, 10-19, 20-29 and 30years shifted from 9.5, 58.3, 25.0 and 7.1% in 1991-1992 to 2.7, 20.5, 39.3 and 37.5% in 2017, respectively.ConclusionsSCE prevalence decreased overall between 1991-1992 and 2017. The age shift observed is probably due to a decrease in the number of new cases of epilepsy resulting from the dramatic reduction of Onchocerca volvulus transmission after 19years of CDTI. |
| |
Language
|
|
|
|
English
| |
Source (journal)
|
|
|
|
Parasites and vectors
| |
Publication
|
|
|
|
2019
| |
ISSN
|
|
|
|
1756-3305
| |
DOI
|
|
|
|
10.1186/S13071-019-3345-7
| |
Volume/pages
|
|
|
|
12
(2019)
, 13 p.
| |
Article Reference
|
|
|
|
114
| |
ISI
|
|
|
|
000462195900001
| |
Pubmed ID
|
|
|
|
30890155
| |
Medium
|
|
|
|
E-only publicatie
| |
Full text (Publisher's DOI)
|
|
|
|
| |
Full text (open access)
|
|
|
|
| |
|